Overall, we identified a peripheral Neuro-Endocrine-Immune pathway SNS/β-ARs/CCL2 in the eustress model to relieve tumor immunosuppression and to overcome PD-1 immunotherapy resistance. Here, CCL2 is linked to neoplasm.